{"id":"W4387562887","doi":"10.1002/cam4.6589","title":"Selinexor for the treatment of recurrent or metastatic salivary gland tumors: Results from the <scp>GEMS</scp>‐001 clinical trial","year":2023,"lang":"en","type":"article","venue":"Cancer Medicine","topic":"Salivary Gland Tumors Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Sociedad Española de Oncología Médica; Princess Margaret Cancer Foundation; Karyopharm Therapeutics; Adenoid Cystic Carcinoma Research Foundation","keywords":"Medicine; Adenoid cystic carcinoma; Acinic cell carcinoma; Internal medicine; Salivary duct carcinoma; Dysgeusia; Adverse effect; Carcinoma; Gastroenterology; Carcinoma ex pleomorphic adenoma; Clinical endpoint; Oncology; Salivary gland; Pleomorphic adenoma; Clinical trial","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001151381,0.000344429,0.001106416,0.00007737969,0.000157214,0.00001220058,0.0002220657,0.00006307509,0.0001687936],"category_scores_gemma":[0.002572722,0.0001264056,0.0003202443,0.0004769063,0.0003196275,0.00002990877,0.00003195056,0.0001620562,0.0000298031],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001268456,"about_ca_system_score_gemma":0.0003678376,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002267466,"about_ca_topic_score_gemma":0.0004935596,"domain_scores_codex":[0.9970385,0.000202924,0.001291418,0.0005454918,0.0005137551,0.0004079001],"domain_scores_gemma":[0.9814783,0.01684588,0.0004436238,0.000821213,0.000182291,0.0002286375],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.069068,0.0050637,0.05511061,0.0001771968,0.005041745,0.0004875623,0.006264227,0.0000337649,0.00001929808,0.0001140141,0.7400951,0.1185248],"study_design_scores_gemma":[0.3518877,0.02647619,0.1874791,0.001448088,0.006743025,0.00003161403,0.002358743,0.001311366,0.0002961613,0.0003466615,0.4214914,0.0001299732],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9444225,0.02006539,0.00002898822,0.0237237,0.004021544,0.005310917,0.002076307,0.0001203569,0.0002302633],"genre_scores_gemma":[0.918991,0.05680897,0.0002098555,0.002158785,0.01202969,0.003315838,0.002579156,0.00009068353,0.003816015],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3186038,"threshold_uncertainty_score":0.5154671,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2460746880662434,"score_gpt":0.4520381901877465,"score_spread":0.2059635021215031,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}